Mapping Endogenous Psychedelic Chemistry: Indolethylamine N-Methyltransferase (INMT) Localizes Proximal to the Golgi Apparatus of Human Neurons
- 1Chemical Neurobiology Laboratory, Center for Genomic Medicine, Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Abstract
N,N-dimethyltryptamine (DMT) is a serotonergic psychedelic with a history of ethnobotanical use and emerging clinical efficacy for neuropsychiatric disorders. Following Julius Axelrod's pioneering studies showing DMT production in human tissues, DMT has been proposed as an endogenous neuromodulator because it is a serotonin 2A receptor (5-HT2A R) agonist. However, the DMT-producing enzyme, indolethylamine N-methyltransferase (INMT), has not been characterized at the protein level in the human central nervous system. Here, we validated an anti-INMT antibody and used immunocytochemistry to show that INMT localizes in close proximity to other DMT biosynthetic enzymes near the cytosolic face of the cis-Golgi network in human induced pluripotent stem cell-derived neurons, with immunoreactivity observed across multiple neuronal Golgi phenotypes. Notably, both DMT-like and 5-HT2A R immunoreactivity also partially localized in close proximity to the Golgi apparatus. Our results establish the first protein-level characterization of INMT in human neurons and identify the cis-Golgi network as a candidate microdomain for psychedelic tryptamine biosynthesis. We propose that INMT catalytic activity at the cis-Golgi network creates an enriched region of membrane-permeable psychedelic tryptamines that can access an intracellular 5- HT2A R pool. These findings provide new tools and insights that can inform efforts to understand the mechanism of action of psychedelics under clinical investigation and to target endogenous tryptamines therapeutically.
Related
- NDE1 Localizes to the Subdistal Appendages to Maintain Centrosome Integrity and Microtubule Organization
- A nucleocapsid-tagged fluorescent pangolin coronavirus enables authentic-virus neutralization assays and localizes the antiviral activity of cepharanthine to viral entry
- SETD3 ACTIN HISTIDINE METHYLTRANSFERASE REGULATES INTESTINAL EPITHELIAL BARRIER INTEGRITY AND MUCOSAL INFLAMMATION
- Genome-Wide Identification of the Caffeoyl Coenzyme A 3-O-Methyltransferase Family Genes and Their Role in the Lodging Resistance of Wheat (Triticum aestivum L.)
- The Histone Methyltransferase KMT2D promotes Natural Killer cell effector molecule release
BibTeX
@misc{will2026mapping,
title = {{Mapping Endogenous Psychedelic Chemistry: Indolethylamine N-Methyltransferase (INMT) Localizes Proximal to the Golgi Apparatus of Human Neurons}},
author = {K. Will and S. Lazaro Martinez and S. A. Reis and S. J. Haggarty},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.30.758666},
url = {https://www.biorxiv.org/content/10.64898/2026.10.30.758666v1},
note = {CC BY},
}
RIS
TY - UNPB
TI - Mapping Endogenous Psychedelic Chemistry: Indolethylamine N-Methyltransferase (INMT) Localizes Proximal to the Golgi Apparatus of Human Neurons
AU - K. Will
AU - S. Lazaro Martinez
AU - S. A. Reis
AU - S. J. Haggarty
PY - 2026
DA - 2026/10/30
PB - bioRxiv
DO - 10.64898/2026.10.30.758666
UR - https://www.biorxiv.org/content/10.64898/2026.10.30.758666v1
AB - N,N-dimethyltryptamine (DMT) is a serotonergic psychedelic with a history of ethnobotanical use and emerging clinical efficacy for neuropsychiatric disorders. Following Julius Axelrod's pioneering studies showing DMT production in human tissues, DMT has been proposed as an endogenous neuromodulator because it is a serotonin 2A receptor (5-HT2A R) agonist. However, the DMT-producing enzyme, indolethylamine N-methyltransferase (INMT), has not been characterized at the protein level in the human central nervous system. Here, we validated an anti-INMT antibody and used immunocytochemistry to show that INMT localizes in close proximity to other DMT biosynthetic enzymes near the cytosolic face of the cis-Golgi network in human induced pluripotent stem cell-derived neurons, with immunoreactivity observed across multiple neuronal Golgi phenotypes. Notably, both DMT-like and 5-HT2A R immunoreactivity also partially localized in close proximity to the Golgi apparatus. Our results establish the first protein-level characterization of INMT in human neurons and identify the cis-Golgi network as a candidate microdomain for psychedelic tryptamine biosynthesis. We propose that INMT catalytic activity at the cis-Golgi network creates an enriched region of membrane-permeable psychedelic tryptamines that can access an intracellular 5- HT2A R pool. These findings provide new tools and insights that can inform efforts to understand the mechanism of action of psychedelics under clinical investigation and to target endogenous tryptamines therapeutically.
ER -